SEATTLE, July 28 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) announced today the publication of data from the pivotal Phase 3 IMPACT study in the New England Journal of Medicine, showing that PROVENGE® (sipuleucel-T) demonstrated a statistically significant improvement in overall survival compared to control in men with asymptomatic or minimally symptomatic metastatic castration resistant prostate cancer (mCRPC).
Henry Ford Hospital Announces New President and CEO
DETROIT, June 9 /PRNewswire/ -- John Popovich Jr., M.D., a nationally respected pulmonary disease and internal medicine specialist, as well as a national leader in health care policy, has been appointed president and chief executive officer of Henry Ford Hospital.
(Photo: http://photos.prnewswire.com/prnh/20100609/DE18585 )
(Photo: http://www.newscom.com/cgi-bin/prnh/20100609/DE18585 )
Dr.
Henry Ford Hospital Announces New President and CEO
DETROIT, June 9 /PRNewswire/ -- John Popovich Jr., M.D., a nationally respected pulmonary disease and internal medicine specialist, as well as a national leader in health care policy, has been appointed president and chief executive officer of Henry Ford Hospital.
Dr.
